HEALTH● LOW1h ago · Oct 20, 2026, 12:50 PM
Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis
CNBC · global
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH27m agoWoman's 3-year wait for donor organ exposes complexity of US transplant systemThe Independent WorldHEALTH30m agoCould your neighbourhood impact your dementia risk? Study links green spaces to lower dementia riskEuroNews [en]HEALTH52m agoChristina Applegate says she was misdiagnosed with multiple sclerosisNBC NewsHEALTH57m agoReps demand urgent action against fake, adulterated food and drinksPremium Times